Blog Post 12

coc222 |

Conner Calzone, Roy Ndebvudzemene, Tiffany Pang

Refine the detailed income statement for your venture for two years (at six-month intervals) or a more appropriate time scale. Explicitly state the assumptions that underlie your financial model.

https://docs.google.com/spreadsheets/d/1UtqK6RgJZu4CY-PxDmE8mOEYOrnFLLXNnSJtWPgsFM8/edit?usp=sharing

 

Assumptions:

  • Sierra Leone and other developing countries may not have the ability to afford the device, so these costs will be taken up by the following partners, potential donors and organizations who have innovation fund programs that could fund our project for several years.
  • Our goal is to make an IMPACT, and national screening program for all newborns. It is not about making a profit. Therefore, profits from bulk sales are reinvested in the project and SCD relief efforts, such as patient support, education, penicillin therapies and into families. Profits from Direct Sales can also be reinvested to organizations like Sickle Cell Society and others
  • The venture will operate with economies of scale and we expect most sales to be from bulk pricing. Current estimations are unit prices of $4.50 for bulk pricing and $5.50 for direct consumer channels.
  • Our plan is to have the health care systems in Sierra Leone well equipped to use the test strip directly and advocate to diagnose 75% of newborns for SCT/SCD in the third year after introducing our device. By year 3, 330,000 units will be sold and distributed to hospitals in the country.

 

 

Refine the Business Model for your venture based on your revenue model. You may use the Osterwalder BMC to refine your business model but prepare one or more visuals that explain how your venture will work and accomplish your BHAG.

 

Business Model

 

Develop an M&E plan for your venture.

Distribution Strategy

    • Our Distribution Strategy consists of receiving grants from donors like WHO or UNICEF to fund our venture. Our device will be made in a manufacturing plant in China and will be shipped to our staff members in Sierra Leone. Then in Sierra Leone, the majority of the devices will be distributed to hospitals while some devices will be distributed to pharmacies. By introducing our device into Sierra Leonean hospitals, we can make a long-lasting impact by diagnosing for SCD early and using our profits to fund SCD relief efforts and treatments like penicillin prophylaxis. For Monitoring and Evaluation, our staff will collect data from hospitals in which our device is in their standard operating procedures. This would be after the hospital staff are trained by our training expert. Then, our project manager will record data like the number of SCD babies born in each hospital, the total births at each hospital and the SCT allele frequency in babies born.
  • Clearly list all assumptions

 

  • We are planning to launch our product in Sierra Leone in Summer 2023. By cross-referencing a population density map and a map of all the public hospitals in Sierra Leone, we have constructed an ordered list of hospitals where we will introduce our device. One year after launch, we expect to be implemented in 10 densely populated hospitals encompassing many areas of the country. Two years after launch, we expect to be in 25 hospitals, and three years after launch, we expect to be in at least 50 hospitals diagnosing 75% of the newborns.
  • To fund our venture, we will need $1.25 million over the next 5 years. Donor Spending on Child Mortality in Sierra Leone will total to $75 million over the next five years. Our venture can eliminate 4% of child mortality in Sierra Leone, so it is well worth the investment from donors.
  • Our staff includes: hiring a project manager, relationship manager, and training expert. Managers will have access to transportation, internet, and networking budgets. Additionally, we will use an advertising budget to raise awareness of the severity of SCD as well as the newborn testing options available. The venture will operate with economies of scale and we expect most sales to be from bulk pricing. Current estimations are unit prices of $4.50 for bulk pricing and $5.50 for direct consumer channels.
  • The newly born infants in Sierra Leone are our target users, yet we plan to sell the devices in bulk to donors such as WHO or UNICEF, who will help distribute them to the public hospitals. Additionally, we have accounted for some direct sales to pharmacies in our sales projections.

 

  • Identify short-term and long-term success metrics.

 

Short-term: We are planning to launch our product in Sierra Leone by the Summer of 2023. The newly born infants in Sierra Leone are our target users, yet we plan to sell the devices in bulk to WHO or UNICEF, who will help distribute them to the public hospitals we prioritize. Our plan is to successfully screen about 75% of newborns in Sierra Leone for SCT/SCD after three years of introducing our device.

Long-term: 5 years from now, our metric for success is the venture being sustainable and autonomous from our input. The operations of the project are to be absorbed into the Sierra Leone Ministry of Health which will continue screening for SCD/SCT in infants. Then from our launch, our goal of about 90% of newborns being diagnosed will be reached.

 

  • Identify specific methods to measure any metrics.

 

  • Our profits from direct sales could be reinvested into organizations such as Sickle Society and education efforts while profits from bulk sales would be reinvested into the project and penicillin prophylaxis treatments, which costs $184 per each saved year of life for SCD patients.
  • Five years from launch, the venture will be sustainable and autonomous from our input as we will shift our focus to look at the intellectual side: strategic gaps, false positives/negatives. The project will be absorbed into the Sierra Leone Ministry of Health which will continue screening for SCD/SCT for newborns because they have the authority and funds to sustain our venture.

 

150 thoughts on “Blog Post 12”

  24. Great article! If you’re having doubts about being in an incompatible relationship, understanding the 7 early signs of a highly compatible relationship is essential. You can also attempt the rice purity test is a fantastic compatible relationship test to explore your similarities and differences with your partner. For further insights, check out the linked article.

    Reply

  26. You’re so cool! I don’t believe I have read through something like this before.
    So wonderful to discover another person with some unique thoughts on this
    topic. Seriously.. thanks for starting this up.
    This web site is something that is needed on the web, someone with a bit of originality!
    프라그마틱 슬롯 사이트

    Reply

  30. Thanks for sharing. I found a lot of interesting information here. A really good post, very thankful and hopeful that you will write many more posts like this one. Tell The Bell

    Reply

  32. Hey there, this is one excellent content. I appreciate you taking the time to provide this important information. The visitors are constantly drawn in by the quality of the material. {dailymag}

    Reply

  41. Your article takes a thoughtful approach to a subject that deserves more attention, and I appreciate the fresh perspective it offers. The way you’ve presented these ideas encourages deeper consideration and exploration. It’s interesting how discussions like this can shape the way we see emerging developments. Thank you for fostering this kind of dialogue. If you have time, check out this article and let me know what you think

    Reply

  42. Your writing has given me much to think about, especially with how you’ve approached this subject. It’s refreshing to see such thoughtful exploration of topics that are so relevant today. I appreciate the way it has challenged my perspective and deepened my understanding. I suspect there’s much more to uncover as these ideas evolve. I shared a similar story here and would love your feedback

    Reply

  44. Thanks for sharing such great information, I highly appreciate your hard-working skills as the post you published have some great information which is quite beneficial for me, I hope you will post more like AZ DMV that in the future. Thanks for the step by step tutorial. Works like a charm! The solution worked for me thanks to the community and the members for the solution.

    Reply

  48. Your approach to developing an M&E plan and a comprehensive distribution strategy for your venture is well-thought-out and impactful. The focus on leveraging grants from renowned organizations like WHO and UNICEF reflects strategic foresight, as these partnerships can provide both credibility and sustainability for your initiative. VIBRA Nicotine Pouches

    Reply

  49. Prioritizing hospitals as the primary distribution point ensures that your device reaches the most critical areas where early SCD diagnosis can have life-saving implications. Additionally, including pharmacies in your distribution plan broadens accessibility, which is vital for community-level impact. goat nicotine pouches dubai

    Reply

Leave a Reply

Your email address will not be published. Required fields are marked *